You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

vascular endothelial growth factor (VEGF)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Retinal Pigment Epithelium Detachment in Neovascular Age-related

Active, not recruiting
  • Neovascular Age-related Macular Degeneration
  • Anti-vascular endothelial growth factor therapy
  • Krasnodar, Russian Federation
    The S.N. Fyodorov Eye Microsurgery State Institution
Jan 12, 2022

Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell

Recruiting
  • Locally Advanced Lung Non-Small Cell Carcinoma
  • +9 more
  • Duarte, California
  • +4 more
Aug 17, 2022

Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8 Trial in Columbus

Recruiting
  • Metastatic Colorectal Carcinoma
  • +4 more
  • Bevacizumab
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 14, 2021

Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in

Not yet recruiting
  • Ovarian Clear Cell Adenocarcinoma
  • +14 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 16, 2022

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Bevacizumab
  • +2 more
  • Los Angeles, California
  • +17 more
Jan 27, 2023

Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular

Completed
  • AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
  • Wenzhou, Zhejiang, China
    The First Affiliated Hospital of Wenzhou Medical University
Nov 6, 2023

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

Not yet recruiting
  • Metastatic Colon Adenocarcinoma
  • +6 more
  • Balstilimab
  • +10 more
  • Duarte, California
    City of Hope Medical Center
Nov 17, 2022

Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (biological, drug, other)

Active, not recruiting
  • Invasive Breast Carcinoma
  • Triple-Negative Breast Carcinoma
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 18, 2022

Acute Myeloid Leukemia, Adult Trial in Mexico city, Mexico City (Experimental group, Control group)

Unknown status
  • Acute Myeloid Leukemia, Adult
  • Experimental group
  • Control group
  • Mexico city, Mexico
  • +1 more
Sep 2, 2020

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +20 more
  • Pembrolizumab
  • Ziv-Aflibercept
  • Tampa, Florida
  • +8 more
Jan 3, 2023

Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States (Dorzolamide-timolol, Artificial

Completed
Has Results
  • Neovascular Age-related Macular Degeneration
  • Wet Macular Degeneration
  • Palo Alto, California
  • +4 more
Jun 5, 2020

Neovascular Age-related Macular Degeneration(nAMD) Trial in Shanghai, Tianjin (HG202)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration(nAMD)
  • HG202
  • Shanghai, Shanghai, China
  • +1 more
Sep 4, 2023

Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,

Not yet recruiting
  • Metastatic Colorectal Carcinoma
  • +3 more
  • Bevacizumab
  • +11 more
  • (no location specified)
May 9, 2023

Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

Recruiting
  • Cervical Adenocarcinoma
  • +47 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +3 more
Dec 5, 2022

Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +38 more
  • Bevacizumab
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Peritoneal Malignant Mesothelioma Trial in United States (biological, drug, procedure)

Recruiting
  • Peritoneal Malignant Mesothelioma
  • Atezolizumab
  • +8 more
  • Phoenix, Arizona
  • +25 more
Feb 2, 2023

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Active, not recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +7 more
  • Anetumab Ravtansine
  • +2 more
  • Orange, California
  • +22 more
Oct 22, 2022

Metastatic Colorectal Carcinoma, Recurrent Colorectal Carcinoma, Refractory Colorectal Carcinoma Trial in United States (drug,

Active, not recruiting
Has Results
  • Metastatic Colorectal Carcinoma
  • +5 more
  • Phoenix, Arizona
  • +9 more
Jan 5, 2022

Analgesia Methods on Vascular Endothelial Growth Factor* and

Completed
  • Breast Cancer
  • Ankara, Turkey
    Dr.Abdurrahman Yurtaslan Ankara Oncology Train and Research Hosp
Oct 21, 2021

Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Stage III Liver Cancer, Stage IV Liver Cancer Trial in United States

Recruiting
  • Combined Hepatocellular Carcinoma and Cholangiocarcinoma
  • +2 more
  • Atezolizumab
  • +6 more
  • Auburn, California
  • +16 more
Aug 17, 2022

Recurrent Glioblastoma Trial in United States (Bevacizumab, Cediranib, Cediranib Maleate)

Active, not recruiting
  • Recurrent Glioblastoma
  • Bevacizumab
  • +3 more
  • La Jolla, California
  • +26 more
Jun 28, 2022

Diabetic Macular Edema, Cataract Trial in Walnut Creek (Bevacizumab, Ranibizumab, Aflibercept)

Recruiting
  • Diabetic Macular Edema
  • Cataract
  • Walnut Creek, California
    Bay Area Retina Associates
Mar 1, 2022

Colorectal Adenocarcinoma, RAS Wild Type, Stage IV Colorectal Cancer AJCC v7 Trial in United States (biological, drug, other)

Completed
Has Results
  • Colorectal Adenocarcinoma
  • +4 more
  • Bevacizumab
  • +4 more
  • Scottsdale, Arizona
  • +12 more
Jan 27, 2022

Neurofibromatosis Type 2, Progressive Vestibular Schwannomas Trial in United States (Bevacizumab)

Completed
Has Results
  • Neurofibromatosis Type 2
  • Progressive Vestibular Schwannomas
  • Los Angeles, California
  • +11 more
Jan 26, 2021

Low Vision, Neovascular Age-related Macular Degeneration Trial in Baltimore (Vision rehabilitation)

Completed
  • Low Vision
  • Neovascular Age-related Macular Degeneration
  • Vision rehabilitation
  • Baltimore, Maryland
    Wilmer Eye Institute
Dec 13, 2019